Benzgalantamine gluconate is a chemical compound that serves as a derivative of galantamine, which is primarily known for its use in the treatment of Alzheimer's disease and other cognitive disorders. This compound is characterized by its ability to inhibit acetylcholinesterase, thereby increasing the levels of acetylcholine in the brain, which is crucial for memory and learning processes. Benzgalantamine gluconate is typically presented as a white to off-white powder and is soluble in water, making it suitable for various pharmaceutical formulations. Its molecular structure includes a benzyl group, which contributes to its pharmacological properties. The compound is subject to rigorous testing for safety and efficacy, as with any pharmaceutical agent, and its use is governed by regulatory standards to ensure patient safety. As with many compounds in this class, potential side effects may include gastrointestinal disturbances and central nervous system effects, necessitating careful monitoring during therapeutic use.

Benzgalantamine is a prodrug of galantamine. Gastrointestinal adverse effects are the most frequently reported side effects in patients undergoing treatment with cholinesterase inhibitors, including galantamine, and are often a reason for treatment discontinuation. As a prodrug, benzagalantamine remains inert as it passes through the stomach, thereby avoiding many of the gastrointestinal effects associated with peripheral cholinesterase inhibition.
Benzgalantamine was approved by the FDA in July 2024 for the treatment of mild-to-moderate dementia in Alzheimer's patients.

Benzgalantamine gluconate

1542321-58-3: Benzgalantamine gluconate is a chemical compound that serves as a derivative of galantamine, which is primarily known for its use in the treatment of Alzheimer's disease and other cognitive disorders. This compound is characterized by its ability to inhibit acetylcholinesterase, thereby increasing the levels of acetylcholine in the brain, which is crucial for memory and learning processes. Benzgalantamine gluconate is typically presented as a white to off-white powder and is soluble in water, making it suitable for various pharmaceutical formulations. Its molecular structure includes a benzyl group, which contributes to its pharmacological properties. The compound is subject to rigorous testing for safety and efficacy, as with any pharmaceutical agent, and its use is governed by regulatory standards to ensure patient safety. As with many compounds in this class, potential side effects may include gastrointestinal disturbances and central nervous system effects, necessitating careful monitoring during therapeutic use.

CAS 1542321-58-3

Benzgalantamine gluconate

Memogain Gluconate (Benzgalantamine Gluconate)

Ref: 4Z-M-337002